Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures

Given the acknowledged lack of success in Alzheimer’s disease (AD) drug development over the past two decades, the objective of this review was to derive key insights from the myriad failures to inform future drug development. A systematic and exhaustive review was performed on all failed AD compoun...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, C. Kwon, Lee, Yin Rui, Ong, Lynnett, Gold, Michael, Kalali, Amir, Sarkar, Joydeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198803/
https://www.ncbi.nlm.nih.gov/pubmed/35342092
http://dx.doi.org/10.3233/JAD-215699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198803/
https://www.ncbi.nlm.nih.gov/pubmed/35342092
http://dx.doi.org/10.3233/JAD-215699

Ejemplares similares